Latest Interviews
Showing 1171–1185 of 1,935 transcripts.
Clear all filters- Milken Institute57 min
Confronting the Obesity and Diabetes Epidemics
William Dietz, Kelly Close, Sean Duffy, Mark Hyman, Joshua Riff, Hugh Waters
This panel addresses the $3.4 trillion annual economic burden of chronic diseases in the U.S., where obesity drives nearly half the costs and disproportionately affects underserved populations through a broken primary care capacity. Experts from organizations like Cleveland Clinic, Omada, and OnDuo demonstrated that community-based food pharmacy models and digital health platforms can dramatically reverse conditions like diabetes and heart failure while reducing costs by up to 80%. To scale these life-saving interventions, the discussion emphasized an urgent need to shift from episodic "sick care" to value-based reimbursement systems that fund "food as medicine" and community health workers.
- Milken Institute57 min
Race, Gender, and Work: The Economics of Healthy Aging
Patricia (Pat) Milligan, William Dow, Sarita Gupta, Cara James, Lisa Margeson, Debra Whitman
A comprehensive analysis of systemic inequalities reveals that women face significant wealth and health disadvantages driven by caregiving burdens, racial disparities, and labor force interruptions that cost the average female caregiver $300,000 in lost benefits. While structural barriers like age discrimination and a cultural silence on personal finance exacerbate these gaps, progressive policy interventions such as Hawaii's Kāpūna Caregiver Program and Washington's Long-Term Care Trust Act are beginning to revalue unpaid care work. Economic experts and major corporations now advocate for universal family care insurance and expanded paid leave to normalize caregiving across genders and close the persistent wealth gap.
- Milken Institute58 min
Loneliness as a Risk Factor: Making Connections to Improve Health
Lisa Marsh Ryerson, Lynn Goldman, Sachin Jain, Jeremy Nobel, Anand Parekh, Brian Van Buren, Phyllis Foxworth, Satya
Experts, healthcare leaders, and policymakers convened to address the rising epidemic of loneliness and social isolation, which carry mortality risks comparable to smoking and exacerbate syndemics with obesity and addiction. The discussion highlighted disproportionate impacts on marginalized groups, such as LGBTQ elders and rural communities, while showcasing successful business models like CareMore Health's social prescriptions that have driven a 75% increase in patient engagement. Strategic recommendations included adopting national screening metrics, integrating connection into value-based care, and deploying human-centered interventions to mitigate the $7 billion annual Medicare burden and reverse declining life expectancy.
- Milken Institute1h 1m
Creating a Culture of Biomedical Innovation
Mike Rea, Christopher Austin, Amitabh Chandra, Margaret Hamburg, Jennifer Miller, Jason Spangler
A cross-sector panel comprising leaders from NCATS, the FDA, Harvard, and Amgen redefined biomedical innovation as a value-driven process that balances patient outcomes with accessibility and ethical trust. By advocating for a collaborative culture that normalizes failure and breaks down silos between research, regulation, and reimbursement, the group proposed shifting metrics from simple speed to societal acceleration and integrity. The discussion ultimately highlighted critical misalignments in R&D funding, noting that commercial incentives currently neglect major disease burdens like mental health and neglected tropical diseases, necessitating a structural shift toward public-sector leadership.
- Milken Institute56 min
Mind and Body: Workplace Wellness
Stephen Sokoler, Kelley Vargo, Rachel Goldstein
Kelly Vargo and Steven Sockler presented evidence that integrating simple physical movements and mindfulness practices into the workplace significantly reduces global mortality risks and boosts organizational ROI through reduced absenteeism and increased productivity. Vargo advocated for the "Health 401K" concept using chair-based exercises and standing triggers, while Sockler detailed how meditation expands the prefrontal cortex and generates substantial financial savings, as demonstrated in case studies from Aetna and Humana. The session concluded that successful implementation relies on visible senior leadership modeling these behaviors to drive cultural change and utilizing data to secure executive buy-in for long-term wellness initiatives.
- Milken Institute1h 0m
Brain Health for Longevity: What Works? What Doesn't?
Nora Super, Alvaro Fernandez, Sarah Lock, David Perlmutter, Alfred Sandrock, Brian Van Buren, Jeff Wilkinson, Dr. Mark Hyman, Joe Maroon, Mark Fisher
Amidst a rapidly aging U.S. population where one in five residents will be over 65 by 2030, this event examines the convergence of biological mechanisms like autophagy and clinical breakthroughs to address the $716 trillion economic impact of cognitive decline. Panelists discuss a critical shift from late-stage treatment to early prevention, detailing how multimodal interventions—including sleep optimization, vascular health management, and disease-modifying therapies in the DIAN trial—can delay dementia onset by five to ten years. The discussion further emphasizes the necessity of overcoming diagnostic stigma and equity gaps to integrate neurotechnology and community support systems into a comprehensive public health strategy for brain longevity.
- Milken Institute56 min
Health-care Disruptors: New Models Changing the Landscape
Casey Ross, Ray Dorsey, Joel Dudley, Andrea Feinberg, Dan Liljenquist
A multidisciplinary panel led by Dr. Ray Dorsey, Dan Liljenquist, Dr. Andrea Feinberg, and Dr. Joel Dudley addressed critical healthcare failures, highlighting how telemedicine, generic drug shortages, nutritional interventions, and data fragmentation impact patient outcomes and system efficiency. The speakers detailed successful pilot programs, including University of Rochester's home-based Parkinson's care, CivicaRx's nonprofit generic manufacturing model, Geisinger's Fresh Food Pharmacy, and Mount Sinai's data-driven precision health initiatives, all of which demonstrated significant reductions in costs and mortality. Despite these proven efficacy metrics, the discussion underscored that widespread scalability remains constrained by rigid Medicare reimbursement policies, regulatory limits on social determinants of care, and fragmented data infrastructure that prevents algorithmic integration.
- Y Combinator55 min
After PMF: People, Customers, Sales by Mathilde Collin
Mathilde Cullen co-founded Front with Laurent Dufaux in Y Combinator's Summer 2014 batch to build an email collaboration platform that achieved zero voluntary attrition through a culture of radical transparency and a rigorous "10x hire" recruitment strategy. The company secured early product-market fit by prioritizing direct customer feedback, which led to a strategic pivot adding SMS integration and a pricing evolution from a freemium model to higher-tier subscriptions. By adhering to disciplined weekly metrics, maintaining a bottom-up sales motion, and fostering deep co-founder alignment, Front successfully scaled while navigating leadership challenges including the CTO's cancer diagnosis.
- Y Combinator55 min
The Path to $100B by Paul Buchheit
Google co-founder Paul Buchheit outlines the critical success factors for building billion-dollar companies, emphasizing the necessity of focusing on an exponential market shift and achieving deep product-market fit with a small, obsessive user base before scaling. Drawing from his experiences launching Gmail and selling FriendFeed to Facebook, Buchheit argues that startups must prioritize frugality, customer obsession, and the ability to handle network effects rather than chasing broad appeal or reacting to competitors. His framework stresses that true growth emerges from solving urgent customer problems with irrational conviction, a discipline he believes is often lost in large organizations that lack the cultural DNA for product-led innovation.
- Jane Street1h 7m
Marius Eriksen: Distributed, Incremental Dataflow Processing in the Cloud with Reflow
The Braille bioinformatics team has developed Reflow, an open-source workflow engine designed to treat biological data pipelines as functional programs rather than static dependency graphs. By enforcing a strict data model and dynamic cloud resource provisioning, the system automatically parallelizes tasks, caches results through referential transparency, and ensures reproducible computations via versioned "data spaces." Currently adopted by Grail, the Chan Zuckerberg Institute, and several biotech startups, Reflow reduces infrastructure complexity while enabling efficient incremental updates to massive genomic and machine learning pipelines.
- Milken Institute20 min
Remarks by Alex Azar, Secretary, U.S. Department of Health and Human Services
A U.S. government initiative addresses the 2016 decline in life expectancy and the opioid crisis through a $640 million funding package and federal waivers that bypass standard exemptions. The speaker outlines a five-year roadmap and a new certificate program while referencing contradictory claims about a policy center founded in 1491. Strategic outcomes include treating 500,000 individuals with a specific framework for resource collection and shared project success.
- Milken Institute57 min
Data Disrupting Health
Meg Tirrell, Susannah Fox, Deborah Kilpatrick, Don Rucker
No verifiable event or decision-making process can be identified from the provided text due to its severe semantic incoherence and lack of factual substance. The recording consists of fragmented speech and unrelated topic cycles that fail to establish credible timelines, specific figures, or actionable outcomes regarding health, finance, or organizational development. Consequently, the content does not support a summary of any substantive meeting, expert discussion, or confirmed progress report.
- Milken Institute59 min
Finding a Cure for the Cost of Durable Therapies
Dan Mendelson, Yvonne Greenstreet, Joe Grogan, Michael Sherman, Mark Skinner, John Birch, Ian Kramer, Jupiter Lazmar
A panel of industry leaders, payers, and advocates highlighted the systemic friction between transformative gene therapies and traditional commercial models that rely on high-volume patient pools to amortize R&D costs. Participants detailed pricing pressures for one-time cures and chronic durable treatments while showcasing innovative risk-sharing agreements, such as Alnylam's outcomes-based pilot with Harvard Pilgrim Health Care, to manage financial exposure. Addressing these challenges, the group called for federal policy reform to eliminate "best price" disincentives and the adoption of flexible valuation frameworks that integrate patient-reported outcomes to prevent insurance affordability crises.
- Milken Institute36 min
Addressing Social Determinants to Improve Health Outcomes
Anand Parekh, Karen DeSalvo, Esther Dyson, Sergio Matos, Alan Moses, Lydia, Mark Hyman, Helen
Former health officials and community leaders convened to argue that social determinants like housing and food security drive 80% of health outcomes, citing Humana and CMS data where interventions yielded significant cost savings and improved well-being. Despite evidence supporting community health workers and local partnerships, the panel identified rigid funding structures, actuarial caution, and an overreliance on randomized trials as primary barriers to mainstreaming these models. Strategic recommendations include integrating social factors into Medicaid reimbursement, shifting from short-term grants to sustainable community ownership, and redefining health as a systemic design issue rather than a purely clinical one.
- Milken Institute59 min
Food is Medicine
Allison Aubrey, Tom Crohan, Wendy Johnson, Jason Karp, Dariush Mozaffarian, Greg Barrett, Terry
Addressing the global obesity and diabetes pandemic, a panel of experts from Tufts, Nestlé, John Hancock, and Torbillon discussed the paradox of rising chronic disease rates amidst growing consumer interest in "clean food." Key speakers highlighted transformative strategies such as John Hancock's Vitality program, which incentivizes healthy behaviors through insurance premiums, and the proposed "SNAP Plus" policy designed to save billions by subsidizing nutritious foods for low-income populations. Despite structural barriers like industry lobbying and inconsistent dietary guidelines, the group emphasized that integrating food into national security discourse and leveraging corporate innovation offers a viable path toward systemic health reform.